Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
Bender A et al (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-135
Pro-inflamatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
Jonuleit H et al (1997) Pro-inflamatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27:3135-3142
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
Thurner B et al (1999) Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 223:1-15
A method for the production of cryopreserved aliquots of antigenpreloaded, mature dendritic cells ready for clinical use
Feuerstein B et al (2000) A method for the production of cryopreserved aliquots of antigenpreloaded, mature dendritic cells ready for clinical use. J Immunol Methods 245:15-29
Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application
Bohnenkamp HR, Noll T (2003) Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application. Cytotechnology 42:121-131
Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors
Dauer M et al (2003) Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol 170:4069-4076
Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes
Obermaier B et al (2003) Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol Proced Online 5:197-203
FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells
Dauer M et al (2005) FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells. J Immunol Methods 302:145-155
Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen
Ramadan G et al (2005) Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol 139:257-267
Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen
Ramadan G et al (2005) Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol 140:81-91
Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6
Ramadan G (2011) Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6. Cytotechnology 63:513-521
Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: Harnessing the immunomodulatory potential of IL-12 without the in vivo -associated toxicity
Emtage PC et al (2003) Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: harnessing the immunomodulatory potential of IL-12 without the in vivo -associated toxicity. J Immunother 26:97-106
Rapid high effi ciency sensitization of CD8 + T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
Xu S et al (2003) Rapid high effi ciency sensitization of CD8 + T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol 171:2251-2261
Cytomegalovirusspecifi c cytolytic T-cell lines and clones generated against adenovirus- pp65-infected dendritic cells
Keever-Taylor CA et al (2001) Cytomegalovirusspecifi c cytolytic T-cell lines and clones generated against adenovirus- pp65-infected dendritic cells. Biol Blood Marrow Transplant 7:247-256
In vitro expansion of human γδ and CD56 + T-cells by Aspergillus -antigen loaded fast dendritic cells in the presence of exogenous interleukin-12
Ramadan G (2012) In vitro expansion of human γδ and CD56 + T-cells by Aspergillus -antigen loaded fast dendritic cells in the presence of exogenous interleukin-12. Immunopharmacol Immunotoxicol 34:309-316
Stimulation by means of dendritic cells followed by Epstein-Barr virustransformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specifi c cytotoxic T cell responses
Zhu F et al (2008) Stimulation by means of dendritic cells followed by Epstein-Barr virustransformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specifi c cytotoxic T cell responses. Clin Exp Immunol 151:284-296